Arvinas Inc
NASDAQ:ARVN

Watchlist Manager
Arvinas Inc Logo
Arvinas Inc
NASDAQ:ARVN
Watchlist
Price: 17.875 USD -3.27% Market Closed
Market Cap: 1.2B USD
Have any thoughts about
Arvinas Inc?
Write Note

Wall Street
Price Targets

ARVN Price Targets Summary
Arvinas Inc

Wall Street analysts forecast ARVN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ARVN is 64.206 USD with a low forecast of 28.28 USD and a high forecast of 115.5 USD.

Lowest
Price Target
28.28 USD
58% Upside
Average
Price Target
64.206 USD
259% Upside
Highest
Price Target
115.5 USD
546% Upside

ARVN Last Price Targets
Arvinas Inc

The latest public price target was made on Oct 31, 2024 by Matthew Biegler from Oppenheimer , who expects ARVN stock to rise by 124% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Matthew Biegler
Oppenheimer
40 USD
Upside 124%
1 month ago
Oct 31, 2024
Arvinas Inc. (ARVN) PT Lowered to $40 at Oppenheimer
StreetInsider
Bradley Canino
Stifel Nicolaus
63 USD
Upside 252%
2 months ago
Oct 21, 2024
Stifel Reiterates Buy Rating on Arvinas Inc. (ARVN)
StreetInsider
Matthew Biegler
Oppenheimer
70 USD
Upside 292%
7 months ago
May 16, 2024
Oppenheimer Reiterates Outperform Rating on Arvinas Inc. (ARVN)
StreetInsider
Andrew Fein
H.C. Wainwright
87 USD
Upside 387%
8 months ago
Apr 12, 2024
Arvinas Inc. (ARVN) PT Lowered to $87 at H.C. Wainwright on Novartis deal
StreetInsider
Bradley Canino
Stifel Nicolaus
72 USD
Upside 303%
8 months ago
Apr 11, 2024
Arvinas Inc. (ARVN) PT Raised to $72 at Stifel, 'strong case to increase ARV-766 sales estimates'
StreetInsider
Derek Archila
Wells Fargo
63 USD
Upside 252%
1 year ago
Dec 19, 2023
Wells Fargo Upgrades Arvinas Inc. (ARVN) to Overweight, 'risk/reward is highly favorable'
StreetInsider
Robert Driscoll
Wedbush
24 USD
Upside 34%
1 year ago
Oct 23, 2023
Wedbush Upgrades Arvinas Inc. (ARVN) to Outperform
StreetInsider
Show More Price Targets
Show Less Price Targets
Matthew Biegler
Oppenheimer
Price Target 40 USD
Upside/Downside 124%
View Source
Bradley Canino
Stifel Nicolaus
Price Target 63 USD
Upside/Downside 252%
View Source
Matthew Biegler
Oppenheimer
Price Target 70 USD
Upside/Downside 292%
View Source
Andrew Fein
H.C. Wainwright
Price Target 87 USD
Upside/Downside 387%
View Source
Bradley Canino
Stifel Nicolaus
Price Target 72 USD
Upside/Downside 303%
View Source
Derek Archila
Wells Fargo
Price Target 63 USD
Upside/Downside 252%
View Source
Robert Driscoll
Wedbush
Price Target 24 USD
Upside/Downside 34%
View Source
Show More Price Targets
Show Less Price Targets
Arvinas Inc Competitors:
Price Targets
002653
Haisco Pharmaceutical Group Co Ltd
14% Upside
GUD
Knight Therapeutics Inc
39% Upside
MEGA
Mega Lifesciences PCL
30% Upside
2096
Simcere Pharmaceutical Group Ltd
40% Upside
4568
Daiichi Sankyo Co Ltd
48% Upside

Revenue
Forecast

Revenue Estimate
Arvinas Inc

For the last 6 years the compound annual growth rate for Arvinas Inc's revenue is 48%. The projected CAGR for the next 4 years is 50%.

48%
Past Growth
50%
Estimated Growth
Estimates Accuracy
2%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Arvinas Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

Net Income
Forecast

Net Income Estimate
Arvinas Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-31%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ARVN's stock price target?
Price Target
64.206 USD

According to Wall Street analysts, the average 1-year price target for ARVN is 64.206 USD with a low forecast of 28.28 USD and a high forecast of 115.5 USD.

What is Arvinas Inc's Revenue forecast?
Projected CAGR
50%

For the last 6 years the compound annual growth rate for Arvinas Inc's revenue is 48%. The projected CAGR for the next 4 years is 50%.

Back to Top